Cargando…
Tumor Lysis Syndrome in a Low-Risk Pancreatic Cancer Patient
Tumor lysis syndrome (TLS) is the most common hematologic emergency encountered during the treatment of high-grade malignancies. While it can lead to death, the prognosis is typically excellent if caught early on in the course. Risk stratification prior to treatment initiation is paramount in decidi...
Autores principales: | Travers, Paul, Goodman, Alexandra, Poiesz, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525293/ https://www.ncbi.nlm.nih.gov/pubmed/34720933 http://dx.doi.org/10.1159/000512827 |
Ejemplares similares
-
Spontaneous Tumor Lysis Syndrome
por: Wesemüller, Wiebke, et al.
Publicado: (2020) -
Hyperuricemia and acute kidney injury secondary to spontaneous tumor lysis syndrome in low risk myelodysplastic syndrome
por: Feng, Yunlin, et al.
Publicado: (2014) -
Tumor lysis syndrome developing intraoperatively
por: Verma, Ankur, et al.
Publicado: (2011) -
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
por: Kim, Jin Ok, et al.
Publicado: (2015) -
Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma
por: Lingamaneni, Prasanth, et al.
Publicado: (2020)